MaxCyte MXCT Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $14.56M-37.8% | $20.07M-28.0% | $12.97M-64.9% | $15.23M-59.4% | $23.39M+5.1% | ||
| $92.3M-19.7% | $82.98M-34.5% | $92.76M-20.6% | $111.34M-7.1% | $114.89M-15.1% | ||
| $21.81M+12.7% | $23.09M+16.5% | $24.27M+16.0% | $20.52M-16.3% | $19.35M-29.8% | ||
| $30.72M-20.7% | $31.37M-26.1% | $32.73M-28.4% | $35.51M-25.8% | $38.74M-18.9% | ||
| $4.21M+14.3% | $4.28M+18.6% | $3M-27.3% | $2.97M+15.3% | $3.68M+14.6% | ||
| $122.94M-21.1% | $118.37M-31.1% | $124.65M-27.9% | $143.22M-18.5% | $155.75M-12.8% | ||
| $16.64M-16.5% | $17.53M-11.0% | $18.62M-11.2% | $19.4M-10.7% | $19.92M-12.6% | ||
| $10.7M-7.3% | $10.92M+1.4% | $11.14M+2.3% | $11.34M+3.1% | $11.54M+3.7% | ||
| $783K— | $650K— | —— | —— | —— | ||
| $2.61M+36.4% | $2.47M+61.0% | $2.58M+146% | $2.8M+337% | $1.91M+548% | ||
| $40.81M+12.0% | $52.57M+46.9% | $52.27M+22.1% | $38.6M-9.1% | $36.42M— | ||
| $194.47M-15.4% | $202.51M-15.4% | $213.48M-14.1% | $219.75M-12.6% | $229.96M-10.8% | ||
| $1.2M-47.5% | $1.4M+3.2% | $1.29M-31.0% | $1.21M+27.0% | $2.28M+36.1% | ||
| $4.37M-13.2% | $7.81M-5.9% | $8.31M+1.3% | $6.4M-9.6% | $5.03M-22.6% | ||
| $3.27M-21.1% | $3.6M-31.5% | $5.2M-21.9% | $2.64M-21.6% | $4.15M-7.4% | ||
| $1.37M+7.7% | $1.46M+68.5% | $1.31M+44.9% | $1.31M+49.0% | $1.28M+54.7% | ||
| $10.21M-19.8% | $14.27M-9.6% | $16.1M-8.6% | $11.56M-5.9% | $12.73M-5.5% | ||
| $16.11M-8.2% | $16.49M-4.0% | $16.85M-3.2% | $17.2M-2.6% | $17.55M-1.5% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $17.49M-7.1% | $17.94M-0.5% | $18.16M-0.9% | $18.51M-0.1% | $18.82M+1.0% | ||
| $262K-3.0% | $263K-4.0% | $227K-18.1% | $248K-20.0% | $270K-3.2% | ||
| $26.59M-13.0% | $31.02M-6.6% | $33.2M-6.0% | $29.03M-4.0% | $30.55M-3.2% | ||
| $1.07M+0.8% | $1.07M+1.0% | $1.07M+1.2% | $1.07M+1.7% | $1.06M+1.8% | ||
| $433.05M+1.8% | $431.91M+2.3% | $431.1M+3.0% | $429.13M+3.4% | $425.46M+3.6% | ||
| -$266.23M-17.2% | -$261.48M-20.6% | -$251.89M-22.1% | -$239.47M-23.0% | -$227.11M-22.5% | ||
| $167.89M-15.8% | $171.49M-16.9% | $180.28M-15.5% | $190.72M-13.8% | $199.41M-11.9% | ||
| $194.47M-15.4% | $202.51M-15.4% | $213.48M-14.1% | $219.75M-12.6% | $229.96M-10.8% | ||
| $2.61M+36.4% | $2.47M+61.0% | $2.58M+146% | $2.8M+337% | $1.91M+548% | ||
| $10.7M-7.3% | $10.92M+1.4% | $11.14M+2.3% | $11.34M+3.1% | $11.54M+3.7% | ||
| $783K— | $650K— | —— | —— | —— | ||
| $40.81M+12.0% | $52.57M+46.9% | $52.27M+22.1% | $38.6M-9.1% | $36.42M— | ||
| $10.7M-7.3% | $10.92M+1.4% | $11.14M+2.3% | $11.34M+3.1% | $11.54M+3.7% | ||
| $2.61M+36.4% | $2.47M+61.0% | $2.58M+146% | $2.8M+337% | $1.91M+548% | ||
| $92.3M-19.7% | $82.98M-34.5% | $92.76M-20.6% | $111.34M-7.1% | $114.89M-15.1% | ||
| $10.7M-7.3% | $10.92M+1.4% | $11.14M+2.3% | $11.34M+3.1% | $11.54M+3.7% | ||
| $2.61M+36.4% | $2.47M+61.0% | $2.58M+146% | $2.8M+337% | $1.91M+548% | ||
| $3.27M-21.1% | $3.6M-31.5% | $5.2M-21.9% | $2.64M-21.6% | $4.15M-7.4% | ||
| $4.37M-13.2% | $7.81M-5.9% | $8.31M+1.3% | $6.4M-9.6% | $5.03M-22.6% | ||
| $17.49M-7.1% | $17.94M-0.5% | $18.16M-0.9% | $18.51M-0.1% | $18.82M+1.0% | ||
| $1.07M+0.8% | $1.07M+1.0% | $1.07M+1.2% | $1.07M+1.7% | $1.06M+1.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are MaxCyte's total assets?
- MaxCyte (MXCT) holds $194.5M in total assets, down 15.4% year over year.
- How much debt does MaxCyte have?
- MaxCyte carries $17.5M in total debt against $167.9M of shareholders' equity, a debt-to-equity ratio of 0.10.
- How much cash does MaxCyte have?
- MaxCyte holds $14.6M in cash and equivalents.
- Can MaxCyte cover its short-term obligations?
- Its current ratio is 12.04 — current assets exceed current liabilities.
- Where does MaxCyte's balance sheet data come from?
- Every line is extracted from MaxCyte's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
